Mingyan Zhao

ORCID: 0000-0003-4287-8586
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • Sepsis Diagnosis and Treatment
  • SARS-CoV-2 and COVID-19 Research
  • Heme Oxygenase-1 and Carbon Monoxide
  • Respiratory Support and Mechanisms
  • Acute Kidney Injury Research
  • Water Treatment and Disinfection
  • Inflammasome and immune disorders
  • Thermal Regulation in Medicine
  • Environmental Chemistry and Analysis
  • Eicosanoids and Hypertension Pharmacology
  • Intensive Care Unit Cognitive Disorders
  • Pharmaceutical and Antibiotic Environmental Impacts
  • Wastewater Treatment and Nitrogen Removal
  • Sulfur Compounds in Biology
  • Immune Response and Inflammation
  • COVID-19 epidemiological studies
  • Metabolomics and Mass Spectrometry Studies
  • COVID-19 Impact on Reproduction
  • SARS-CoV-2 detection and testing
  • Vagus Nerve Stimulation Research
  • Immune responses and vaccinations
  • COVID-19 diagnosis using AI
  • Nosocomial Infections in ICU

Harbin Medical University
2016-2025

First Affiliated Hospital of Harbin Medical University
2016-2025

Heilongjiang Provincial Hospital
2023-2025

Beijing University of Technology
2021-2024

Education Department of Heilongjiang Province
2024

People 's Hospital of Jilin Province
2024

National Health and Family Planning Commission
2021

Second Affiliated Hospital of Harbin Medical University
2020

Introduction Information about sepsis in mainland China remains scarce and incomplete. The purpose of this study was to describe the epidemiology outcome severe septic shock mixed ICU China, as well independent predictors mortality. Methods We performed a 2-month prospective, observational cohort 22 closed multi-disciplinary intensive care units (ICUs). All admissions into those ICUs during period were screened patients with or included. Results A total 484 patients, 37.3 per 100 diagnosed...

10.1371/journal.pone.0107181 article EN cc-by PLoS ONE 2014-09-16

Abstract Background Sepsis-associated acute kidney injury (SA-AKI) is a frequent complication in patients with sepsis and associated high mortality. Therefore, early recognition of SA-AKI essential for administering supportive treatment preventing further damage. This study aimed to identify validate metabolite biomarkers assist clinical diagnosis. Methods Untargeted renal proteomic metabolomic analyses were performed on the tissues LPS-induced mice. Glomerular filtration rate (GFR)...

10.1186/s12916-025-03920-7 article EN cc-by BMC Medicine 2025-02-11

Background Hydrogen sulfide (H2S) displays vasodilative, anti-oxidative, anti-inflammatory and cytoprotective activities. Impaired production of H2S contributes to the increased intrahepatic resistance in cirrhotic livers. The study aimed investigate roles carbon tetrachloride (CCl4)-induced hepatotoxicity, cirrhosis portal hypertension. Methods Findings Sodium hydrosulfide (NaHS), a donor H2S, DL-propargylglycine (PAG), an irreversible inhibitor cystathionine γ-lyase (CSE), were applied...

10.1371/journal.pone.0025943 article EN cc-by PLoS ONE 2011-10-14

Hydrogen sulfide (H2S) displays anti-inflammatory and cytoprotective activities as evidenced by the inhibition of myocardial ischemia-reperfusion injury production lipid peroxidation. H2S also exerts many physiological or pathological effects on livers. Therefore, we designed present study to investigate roles in hepatic (HIR)–induced rats measuring levels, synthesizing activity, cystathionine γ-lyase (CSE) messenger RNA (mRNA) expression. We applied DL-propargyl glycine (PAG) sodium...

10.1002/lt.21810 article EN Liver Transplantation 2009-09-29

No therapeutics have been proven effective yet for the treatment of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome 2 (SARS-CoV-2). To assess efficacy and safety Triazavirin therapy COVID-19, we conducted a randomized, double-blinded controlled trial involving hospitalized adult patients with COVID-19. Participants were enrolled from ten sites, randomized into two arms study ratio 1:1. Patients treated 250 mg versus placebo three or four times day 7 d. The...

10.1016/j.eng.2020.08.011 article EN cc-by-nc-nd Engineering 2020-09-08

Although the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant has spread, data on clinical characteristics of infected patients are limited. In this study, demographic, characteristics, and laboratory 310 SARS-CoV-2 treated at Haihe Hospital Tianjin were collected analyzed. Information these was compared to 96 with Delta concern (VOC) 326 Beta VOC during previous disease 2019 (COVID-19) outbreak in Harbin. Of variant, median age 35 years. Most clinically...

10.1016/j.virs.2022.07.014 article EN cc-by-nc-nd Virologica Sinica 2022-08-07

To establish a prediction model and assess the risk factors for severe diabetic ketoacidosis (DKA) in adult patients during ICU.With DKA hospitalization rates consistently increasing, in-hospital mortality has become growing concern.DKA aged >18 years old US-based critical care database (Medical Information Mart Intensive Care (MIMIC-IV)) were considered. Independent screened using extreme gradient boosting (XGBoost) Bayesian information criterion (BIC) optimal subset regression. One...

10.1016/j.ijmedinf.2023.105049 article EN cc-by-nc-nd International Journal of Medical Informatics 2023-03-27

We sought to describe the demographics, case mix, interventions, and clinical outcome of critically ill patients admitted ICUs in Mainland China.A 2-month (July 1, 2009, August 31, 2009) prospective, observational cohort study.Twenty-two China.Adult participating during study period with an ICU length stay >24 hrs.None.Patient characteristics, including underlying diseases, severity illness, admission status, complications, intervention treatment stay, were recorded report form. The primary...

10.1097/ccm.0b013e31826a4082 article EN Critical Care Medicine 2012-12-06

Abstract Coronavirus disease (COVID‐19) was first diagnosed in Wuhan December 2019. The World Health Organization defined the subsequent outbreak of COVID‐19 worldwide as a public health emergency international concern. Epidemiological data indicate that at least 20% patients have severe disease. In addition to impairment respiratory system, acute kidney injury (AKI) is major complication. Immune damage mediated by cytokine storms and concomitant AKI key factor for poor prognosis. Based on...

10.1016/j.cdtm.2020.04.002 article EN cc-by-nc-nd Chronic Diseases and Translational Medicine 2020-04-28

Septic shock comprises a heterogeneous population, and individualized resuscitation strategy is of vital importance. The study aimed to identify subclasses septic with non-supervised learning algorithms, so as tailor for each class.Patients in 25 tertiary care teaching hospitals China from January 2016 December 2017 were enrolled the study. Clinical laboratory variables collected on days 0, 1, 2, 3 7 after ICU admission. Subclasses identified by both finite mixture modeling K-means...

10.1186/s13054-021-03682-7 article EN cc-by Critical Care 2021-07-12

Abstract Tremendous efforts have been made to improve diagnosis and treatment of COVID-19, but knowledge on long-term complications is limited. In particular, a large portion survivors has respiratory complications, currently, experienced radiologists state-of-the-art artificial intelligence systems are not able detect many abnormalities from follow-up computerized tomography (CT) scans COVID-19 survivors. Here we propose Deep-LungParenchyma-Enhancing (DLPE), computer-aided detection (CAD)...

10.1038/s42256-022-00483-7 article EN cc-by Nature Machine Intelligence 2022-05-23

Acute kidney injury (AKI), which is associated with high mortality rates, involves renal inflammation related to the activation of innate immunity. The inflammatory response in AKI inflammasome, integrates danger signals into caspase-1-activating platforms, leading processing and secretion proinflammatory cytokines interleukin (IL)-1β IL-18. nucleotide-binding domain-like receptor protein 3 (NLRP3) inflammasome plays a role development many diseases, including AKI. However, mechanisms by...

10.1111/febs.13379 article EN FEBS Journal 2015-07-22
Coming Soon ...